MIC
PJP icon

Means Investment Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Means Investment Company’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$305K Sell
2,938
-344
-10% -$36.3K 0.03% 162
2025
Q4 		$343K Buy
3,282
+4
+0.1% +$402 0.03% 145
2025
Q3 		$303K Buy
3,278
+5
+0.2% +$438 0.03% 160
2025
Q2 		$261K Buy
3,273
+6
+0.2% +$479 0.02% 172
2025
Q1 		$283K Sell
3,267
-67
-2% -$5.71K 0.03% 162
2024
Q4 		$275K Buy
3,334
+6
+0.2% +$516 0.03% 175
2024
Q3 		$289K Buy
3,328
+4
+0.1% +$342 0.03% 169
2024
Q2 		$273K Buy
3,324
+5
+0.2% +$397 0.03% 163
2024
Q1 		$266K Sell
3,319
-750
-18% -$58.1K 0.03% 172
2023
Q4 		$310K Sell
4,069
-299
-7% -$21.4K 0.04% 157
2023
Q3 		$316K Sell
4,368
-612
-12% -$46.9K 0.05% 155
2023
Q2 		$377K Buy
4,980
+7
+0.1% +$534 0.06% 140
2023
Q1 		$378K Sell
4,973
-93
-2% -$7.17K 0.07% 138
2022
Q4 		$398K Buy
5,066
+7
+0.1% +$538 0.08% 132
2022
Q3 		$361K Buy
5,059
+7
+0.1% +$522 0.08% 136
2022
Q2 		$379K Buy
5,052
+9
+0.2% +$682 0.08% 131
2022
Q1 		$401K Buy
5,043
+8
+0.2% +$620 0.07% 130
2021
Q4 		$408K Buy
5,035
+7
+0.1% +$553 0.07% 133
2021
Q3 		$389K Buy
5,028
+255
+5% +$20.6K 0.08% 132
2021
Q2 		$384K Buy
4,773
+5
+0.1% +$397 0.08% 137
2021
Q1 		$376K Buy
4,768
+6
+0.1% +$468 0.09% 127
2020
Q4 		$386K Buy
4,762
+5
+0.1% +$335 0.09% 121
2020
Q3 		$309K Sell
4,757
-119
-2% -$7.78K 0.08% 112
2020
Q2 		$319K Buy
4,876
+7
+0.1% +$435 0.1% 106
2020
Q1 		$293K Buy
4,869
+7
+0.1% +$426 0.11% 99
2019
Q4 		$322K Sell
4,862
-437
-8% -$26.6K 0.11% 113
2019
Q3 		$320K Buy
5,299
+7
+0.1% +$403 0.12% 113
2019
Q2 		$318K Sell
5,292
-493
-9% -$30.2K 0.13% 112
2019
Q1 		$377K Sell
5,785
-455
-7% -$29.9K 0.17% 98
2018
Q4 		$389K Buy
+6,240
New +$421K 0.22% 81

Other funds holding PJP

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Means Investment Company's PJP Position: Q1 2026 in Review

Means Investment Company reduced its Invesco Pharmaceuticals ETF (PJP) stake by 10% in Q1 2026, selling an estimated $36.3K and leaving 2,938 shares worth $305K. The position accounts for 0.03% of the portfolio, ranked #162.

Means Investment Company first reported a position in PJP in Q4 2018 and has held it in 30 quarters since. The position peaked at $408K in Q4 2021. 119 funds tracked by Wall St. Rank hold PJP as of Q1 2026.

  • Means Investment Company held 2,938 shares of Invesco Pharmaceuticals ETF worth $305K as of Q1 2026.
  • Means Investment Company sold 344 Invesco Pharmaceuticals ETF shares in Q1 2026, an estimated $36.3K.
  • Invesco Pharmaceuticals ETF made up 0.03% of Means Investment Company's portfolio in Q1 2026, its #162 holding.
  • Means Investment Company first reported a position in Invesco Pharmaceuticals ETF in Q4 2018 and has held it in 30 quarters since.
  • Means Investment Company's Invesco Pharmaceuticals ETF position peaked at $408K in Q4 2021.
  • 119 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2026.

Based on Means Investment Company's 13F filing for Q1 2026, filed 24 Apr 2026.